Seattle startup lands $5M for ‘tumor paint’ to ID cancer cells

A Seattle startup that spun out of the Fred Hutchinson Cancer Research Center has raised $5 million in series A funding to develop what it calls “tumor paint.” Blaze Bioscience’s experimental “tumor paint” technology is described as a real-time, high-resolution visualization of cancer cells. From the press release: By binding to and illuminating cancer cells, Tumor Paint… Read More